Overview
- Basque Government, Spain’s central government and Kutxa Fundazioa participated in the capital increase reported at approximately €58 million.
- Oncomatryx plans to build a manufacturing facility in Gipuzkoa to relocate production currently carried out in Taiwan, with the specific site yet to be determined.
- The company says the funding will accelerate its shift from an R&D-focused biotech to an operation spanning discovery, clinical development and commercialization.
- Kutxa Fundazioa confirmed a €15 million commitment, citing the project’s value for the region’s life sciences ecosystem.
- Founded in 2000 by Dr. Laureano Simón, the Derio-based firm develops next-generation therapies targeting hard-to-treat and metastatic cancers.